stockrow
Saturday 7 November 2026
Export KTTA’s income statement to Excel — free account
Pasithea Therapeutics Corp.
KTTA Healthcare Biotechnology
- EPS
- +75.8%
- Free cash flow
- −21.7%
Quarter to June 2026, against a year earlier
0.58
0.06
+11.54%
Follow KTTA
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
24.90 | 33.91 | 11.11 | 3.07 | |
Current Ratio |
26.25 | 35.40 | 11.35 | 4.02 | |
Net Debt/EBITDA |
8.24 | 10.70 | 5.47 | 1.44 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 1.67 | 0.53 | 0.95 | |
Capex/Depreciation |
0.00 | 0.00 | 0.07 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.07 | 0.06 | 0.06 | 0.59 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.15) | (0.20) | (0.42) | (0.39) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.15) | (0.20) | (0.42) | (0.39) | |
Cash per Share |
1.43 | 2.08 | 4.31 | 0.57 | |
Shareholders Equity per Share |
1.55 | 2.25 | 4.30 | 1.64 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.55 | 2.25 | 4.30 | 1.64 | |
Free Cash Flow |
(4.71) | (4.79) | (5.39) | (2.89) | |
Working Capital |
46.41 | 51.24 | 51.49 | 4.15 | |
Capital Expenditures |
— | — | 0.01 | — | |
Net Current Asset Value |
46.37 | 51.19 | 51.44 | 4.11 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | 0.00 | — | |
| Other line items | |||||
Average Payables |
1.71 | 1.41 | 1.13 | 1.00 | |
Average Assets |
34.36 | 35.51 | 38.15 | 16.13 | |
Average Common Equity |
32.51 | 33.90 | 35.00 | 15.01 |
Columns are period end dates · fundamentals updated 26 Oct 2026